Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Marc Goodman is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/25/2025 | OPT | Buy Now | Opthea | $3.31 | -69.79% | Marc Goodman74% | $12 → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/10/2025 | AXSM | Buy Now | Axsome Therapeutics | $120.69 | 24.29% | Marc Goodman74% | $110 → $150 | Maintains | Outperform | Get Alert |
| 12/04/2024 | RLMD | Buy Now | Relmada Therapeutics | $0.31 | 220% | Marc Goodman74% | $10 → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 09/23/2024 | BHVN | Buy Now | Biohaven | $29.88 | 100.8% | Marc Goodman74% | $55 → $60 | Maintains | Outperform | Get Alert |
| 04/15/2024 | LENZ | Buy Now | LENZ Therapeutics | $26.66 | 20.03% | Marc Goodman74% | → $32 | Initiates | → Outperform | Get Alert |
| 03/11/2024 | AMLX | Buy Now | Amylyx Pharma | $3.69 | — | Marc Goodman74% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/26/2023 | BLTE | Buy Now | Belite Bio | $66.94 | -62.66% | Marc Goodman74% | → $25 | Initiates | → Outperform | Get Alert |
| 03/01/2023 | APTX | Buy Now | Aptinyx | — | — | Marc Goodman74% | → $0.5 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/30/2023 | DNLI | Buy Now | Denali Therapeutics | $14.31 | 249.41% | Marc Goodman74% | → $50 | Initiates | → Outperform | Get Alert |
| 01/24/2023 | BHVN | Buy Now | Biohaven | $29.88 | -19.68% | Marc Goodman74% | → $24 | Initiates | → Outperform | Get Alert |
| 01/23/2023 | RLMD | Buy Now | Relmada Therapeutics | $0.31 | 3100% | Marc Goodman74% | $42 → $10 | Maintains | Outperform | Get Alert |
| 01/23/2023 | MRNS | Buy Now | Marinus Pharma | — | — | Marc Goodman74% | $27 → $23 | Maintains | Outperform | Get Alert |
| 01/19/2023 | EOLS | Buy Now | Evolus | $12.99 | 53.96% | Marc Goodman74% | $18 → $20 | Maintains | Outperform | Get Alert |
| 11/29/2022 | AXSM | Buy Now | Axsome Therapeutics | $120.69 | -29.57% | Marc Goodman74% | $65 → $85 | Maintains | Outperform | Get Alert |
| 11/15/2022 | STSA | Buy Now | Satsuma Pharma | — | — | Marc Goodman74% | $15 → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/02/2022 | NBIX | Buy Now | Neurocrine Biosciences | $115.17 | -0.15% | Marc Goodman74% | $100 → $115 | Maintains | Market Perform | Get Alert |
| 10/26/2022 | BIIB | Buy Now | Biogen | $139.81 | 121.73% | Marc Goodman74% | $270 → $310 | Maintains | Outperform | Get Alert |
| 10/10/2022 | STSA | Buy Now | Satsuma Pharma | — | — | Marc Goodman74% | $5 → $15 | Upgrade | Market Perform → Outperform | Get Alert |
| 09/08/2022 | AMLX | Buy Now | Amylyx Pharma | $3.69 | 1253.18% | Marc Goodman74% | $31 → $50 | Maintains | Outperform | Get Alert |
| 08/22/2022 | AXSM | Buy Now | Axsome Therapeutics | $120.69 | -37.85% | Marc Goodman74% | $50 → $75 | Maintains | Outperform | Get Alert |
| 08/16/2022 | ELYM | Buy Now | Eliem Therapeutics | — | — | Marc Goodman74% | $9 → $4 | Maintains | Outperform | Get Alert |
| 08/11/2022 | AVDL | Buy Now | Avadel Pharmaceuticals | $8.53 | 40.68% | Marc Goodman74% | $6 → $12 | Maintains | Outperform | Get Alert |
| 08/11/2022 | XENE | Buy Now | Xenon Pharmaceuticals | $34.69 | 32.6% | Marc Goodman74% | $40 → $46 | Maintains | Outperform | Get Alert |
| 08/09/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | Marc Goodman74% | $170 → $270 | Maintains | Outperform | Get Alert |
| 08/09/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.05 | 23.2% | Marc Goodman74% | $27 → $21 | Maintains | Outperform | Get Alert |
| 08/05/2022 | APTX | Buy Now | Aptinyx | — | — | Marc Goodman74% | $4 → $3 | Maintains | Outperform | Get Alert |
| 08/04/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.28 | 56.39% | Marc Goodman74% | $200 → $210 | Maintains | Outperform | Get Alert |
| 07/14/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | Marc Goodman74% | → $170 | Initiates | → Outperform | Get Alert |
| 07/11/2022 | SAGE | Buy Now | Sage Therapeutics | $8.04 | 397.51% | Marc Goodman74% | $50 → $40 | Maintains | Market Perform | Get Alert |
| 07/11/2022 | ELYM | Buy Now | Eliem Therapeutics | — | — | Marc Goodman74% | $13 → $9 | Maintains | Outperform | Get Alert |
| 07/11/2022 | ACIU | Buy Now | AC Immune | $2.00 | 398.75% | Marc Goodman74% | $15 → $10 | Maintains | Outperform | Get Alert |
| 07/11/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.05 | 58.4% | Marc Goodman74% | $31 → $27 | Maintains | Outperform | Get Alert |
| 05/27/2022 | AVDL | Buy Now | Avadel Pharmaceuticals | $8.53 | -29.66% | Marc Goodman74% | $18 → $6 | Maintains | Outperform | Get Alert |
| 05/11/2022 | BHVN | Buy Now | Biohaven | $29.88 | — | Marc Goodman74% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 04/28/2022 | ALKS | Buy Now | Alkermes | $34.26 | -21.19% | Marc Goodman74% | $24 → $27 | Maintains | Market Perform | Get Alert |
| 04/26/2022 | OPT | Buy Now | Opthea | $3.31 | 655.29% | Marc Goodman74% | → $25 | Initiates | → Outperform | Get Alert |
| 04/26/2022 | ELYM | Buy Now | Eliem Therapeutics | — | — | Marc Goodman74% | $33 → $13 | Maintains | Outperform | Get Alert |
| 04/21/2022 | ITCI | Buy Now | Intra-Cellular Therapies | $131.70 | -46.85% | Marc Goodman74% | $65 → $70 | Maintains | Outperform | Get Alert |
| 04/21/2022 | BIIB | Buy Now | Biogen | $139.81 | 93.12% | Marc Goodman74% | $300 → $270 | Maintains | Outperform | Get Alert |
| 04/21/2022 | APTX | Buy Now | Aptinyx | — | — | Marc Goodman74% | $10 → $4 | Maintains | Outperform | Get Alert |
| 04/21/2022 | ALKS | Buy Now | Alkermes | $34.26 | -27.03% | Marc Goodman74% | $24 → $25 | Maintains | Market Perform | Get Alert |
| 03/31/2022 | AMLX | Buy Now | Amylyx Pharma | $3.69 | 738.97% | Marc Goodman74% | $50 → $31 | Maintains | Outperform | Get Alert |
| 03/22/2022 | MRNS | Buy Now | Marinus Pharma | — | — | Marc Goodman74% | $30 → $27 | Maintains | Outperform | Get Alert |
| 03/03/2022 | GMTX | Buy Now | Gemini Therapeutics | — | — | Marc Goodman74% | $10 → $2 | Downgrade | Outperform → Market Perform | Get Alert |
| 03/02/2022 | ITCI | Buy Now | Intra-Cellular Therapies | $131.70 | -50.65% | Marc Goodman74% | $50 → $65 | Maintains | Outperform | Get Alert |
| 03/02/2022 | AXSM | Buy Now | Axsome Therapeutics | $120.69 | -58.57% | Marc Goodman74% | $65 → $50 | Maintains | Outperform | Get Alert |
| 02/25/2022 | SAGE | Buy Now | Sage Therapeutics | $8.04 | 521.89% | Marc Goodman74% | $60 → $50 | Maintains | Market Perform | Get Alert |
| 02/01/2022 | AMLX | Buy Now | Amylyx Pharma | $3.69 | 1253.18% | Marc Goodman74% | → $50 | Initiates | → Outperform | Get Alert |
| 01/24/2022 | GMTX | Buy Now | Gemini Therapeutics | — | — | Marc Goodman74% | $15 → $10 | Maintains | Outperform | Get Alert |
| 01/24/2022 | BIIB | Buy Now | Biogen | $139.81 | 114.58% | Marc Goodman74% | $325 → $300 | Maintains | Outperform | Get Alert |
| 12/21/2021 | ALDX | Buy Now | Aldeyra Therapeutics | $6.59 | 127.45% | Marc Goodman74% | $24 → $15 | Maintains | Outperform | Get Alert |
| 12/20/2021 | ZGNX | Buy Now | Zogenix | — | — | Marc Goodman74% | $37 → $32 | Maintains | Outperform | Get Alert |
| 12/20/2021 | SAGE | Buy Now | Sage Therapeutics | $8.04 | 646.27% | Marc Goodman74% | $70 → $60 | Maintains | Market Perform | Get Alert |
| 12/20/2021 | RLMD | Buy Now | Relmada Therapeutics | $0.31 | 13340% | Marc Goodman74% | $50 → $42 | Maintains | Outperform | Get Alert |
| 12/20/2021 | MRNS | Buy Now | Marinus Pharma | — | — | Marc Goodman74% | $32 → $30 | Maintains | Outperform | Get Alert |
| 12/20/2021 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.28 | 48.94% | Marc Goodman74% | $230 → $200 | Maintains | Outperform | Get Alert |
| 12/20/2021 | ITCI | Buy Now | Intra-Cellular Therapies | $131.70 | -62.03% | Marc Goodman74% | $45 → $50 | Maintains | Outperform | Get Alert |
| 12/20/2021 | GMTX | Buy Now | Gemini Therapeutics | — | — | Marc Goodman74% | $25 → $15 | Maintains | Outperform | Get Alert |
| 12/20/2021 | BIIB | Buy Now | Biogen | $139.81 | 132.46% | Marc Goodman74% | $450 → $325 | Maintains | Outperform | Get Alert |
| 12/20/2021 | APTX | Buy Now | Aptinyx | — | — | Marc Goodman74% | $12 → $10 | Maintains | Outperform | Get Alert |
| 12/20/2021 | ACIU | Buy Now | AC Immune | $2.00 | 648.13% | Marc Goodman74% | $17 → $15 | Maintains | Outperform | Get Alert |
| 11/11/2021 | XENE | Buy Now | Xenon Pharmaceuticals | $34.69 | 15.31% | Marc Goodman74% | $34 → $40 | Maintains | Outperform | Get Alert |
| 11/09/2021 | AXSM | Buy Now | Axsome Therapeutics | $120.69 | -46.14% | Marc Goodman74% | $75 → $65 | Maintains | Outperform | Get Alert |
| 11/09/2021 | ALKS | Buy Now | Alkermes | $34.26 | -29.95% | Marc Goodman74% | $27 → $24 | Maintains | Market Perform | Get Alert |
| 09/07/2021 | ELYM | Buy Now | Eliem Therapeutics | — | — | Marc Goodman74% | → $33 | Initiates | → Outperform | Get Alert |
| 08/10/2021 | AXSM | Buy Now | Axsome Therapeutics | $120.69 | -37.85% | Marc Goodman74% | $115 → $75 | Maintains | Outperform | Get Alert |
| 08/06/2021 | ZGNX | Buy Now | Zogenix | — | — | Marc Goodman74% | $42 → $37 | Maintains | Outperform | Get Alert |
| 08/05/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.05 | 64.27% | Marc Goodman74% | $31 → $28 | Maintains | Outperform | Get Alert |
| 07/29/2021 | ALKS | Buy Now | Alkermes | $34.26 | -27.03% | Marc Goodman74% | $23 → $25 | Maintains | Market Perform | Get Alert |
| 06/18/2021 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.28 | 71.28% | Marc Goodman74% | $210 → $230 | Maintains | Outperform | Get Alert |
| 06/16/2021 | SAGE | Buy Now | Sage Therapeutics | $8.04 | 770.65% | Marc Goodman74% | $90 → $70 | Maintains | Market Perform | Get Alert |
| 06/10/2021 | BIIB | Buy Now | Biogen | $139.81 | 239.75% | Marc Goodman74% | $380 → $475 | Maintains | Outperform | Get Alert |
| 05/13/2021 | GRAY | Buy Now | Graybug Vision | — | — | Marc Goodman74% | $322 → $70 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/12/2021 | STSA | Buy Now | Satsuma Pharma | — | — | Marc Goodman74% | $4 → $5 | Maintains | Market Perform | Get Alert |
| 05/12/2021 | BHVN | Buy Now | Biohaven | $29.88 | 251.41% | Marc Goodman74% | $115 → $105 | Maintains | Outperform | Get Alert |
| 05/06/2021 | NBIX | Buy Now | Neurocrine Biosciences | $115.17 | -13.18% | Marc Goodman74% | $110 → $100 | Maintains | Market Perform | Get Alert |
| 04/08/2021 | GMTX | Buy Now | Gemini Therapeutics | — | — | Marc Goodman74% | → $25 | Initiates | → Outperform | Get Alert |
| 03/12/2021 | ALDX | Buy Now | Aldeyra Therapeutics | $6.59 | 233.59% | Marc Goodman74% | → $22 | Initiates | → Outperform | Get Alert |
| 03/09/2021 | GRAY | Buy Now | Graybug Vision | — | — | Marc Goodman74% | $630 → $322 | Maintains | Outperform | Get Alert |
| 03/02/2021 | XENE | Buy Now | Xenon Pharmaceuticals | $34.69 | -19.29% | Marc Goodman74% | $25 → $28 | Maintains | Outperform | Get Alert |
| 02/04/2021 | BIIB | Buy Now | Biogen | $139.81 | 171.8% | Marc Goodman74% | $430 → $380 | Maintains | Outperform | Get Alert |
| 02/04/2021 | GWPH | Buy Now | GW Pharmaceuticals | — | — | Marc Goodman74% | $200 → $220 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/11/2020 | ALKS | Buy Now | Alkermes | $34.26 | -32.87% | Marc Goodman74% | $18 → $23 | Maintains | Market Perform | Get Alert |
| 12/07/2020 | BHVN | Buy Now | Biohaven | $29.88 | 301.61% | Marc Goodman74% | $85 → $120 | Maintains | Outperform | Get Alert |
| 11/13/2020 | APTX | Buy Now | Aptinyx | — | — | Marc Goodman74% | $14 → $12 | Maintains | Outperform | Get Alert |
| 11/10/2020 | NBIX | Buy Now | Neurocrine Biosciences | $115.17 | -13.18% | Marc Goodman74% | $120 → $100 | Maintains | Market Perform | Get Alert |
| 11/09/2020 | BIIB | Buy Now | Biogen | $139.81 | 173.23% | Marc Goodman74% | $402 → $382 | Maintains | Outperform | Get Alert |
| 11/05/2020 | BIIB | Buy Now | Biogen | $139.81 | 187.53% | Marc Goodman74% | $342 → $402 | Maintains | Outperform | Get Alert |
| 10/20/2020 | GRAY | Buy Now | Graybug Vision | — | — | Marc Goodman74% | → $490 | Initiates | → Outperform | Get Alert |
| 10/02/2020 | XENE | Buy Now | Xenon Pharmaceuticals | $34.69 | -36.58% | Marc Goodman74% | → $22 | Initiates | → Outperform | Get Alert |
| 09/15/2020 | MRNS | Buy Now | Marinus Pharma | — | — | Marc Goodman74% | $24 → $32 | Maintains | Outperform | Get Alert |
| 09/11/2020 | STSA | Buy Now | Satsuma Pharma | — | — | Marc Goodman74% | $35 → $4 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/19/2020 | BIIB | Buy Now | Biogen | $139.81 | 144.62% | Marc Goodman74% | $350 → $342 | Maintains | Outperform | Get Alert |
| 08/06/2020 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.05 | 205.07% | Marc Goodman74% | $56 → $52 | Maintains | Outperform | Get Alert |
| 08/04/2020 | NBIX | Buy Now | Neurocrine Biosciences | $115.17 | 4.19% | Marc Goodman74% | $105 → $120 | Maintains | Market Perform | Get Alert |
| 04/03/2020 | EOLS | Buy Now | Evolus | $12.99 | 15.47% | Marc Goodman74% | $25 → $15 | Maintains | Outperform | Get Alert |
| 03/13/2020 | ULTA | Buy Now | Ulta Beauty | $368.00 | -26.63% | Marc Goodman74% | $300 → $270 | Maintains | Buy | Get Alert |
| 02/06/2020 | BIIB | Buy Now | Biogen | $139.81 | 193.26% | Marc Goodman74% | $350 → $410 | Maintains | Outperform | Get Alert |
| 12/06/2019 | SAGE | Buy Now | Sage Therapeutics | $8.04 | — | Marc Goodman74% | — | Upgrade | Underperform → Market Perform | Get Alert |
| 11/26/2019 | EOLS | Buy Now | Evolus | $12.99 | 92.46% | Marc Goodman74% | → $25 | Initiates | → Outperform | Get Alert |
| 11/19/2019 | ABBV | Buy Now | AbbVie | $199.41 | -51.86% | Marc Goodman74% | $79 → $96 | Maintains | Buy | Get Alert |
| 11/19/2019 | AGN | Buy Now | Allergan | — | — | Marc Goodman74% | $189 → $203 | Downgrade | Buy → Neutral | Get Alert |
| 10/23/2019 | BIIB | Buy Now | Biogen | $139.81 | 150.34% | Marc Goodman74% | $256 → $350 | Upgrade | Market Perform → Outperform | Get Alert |
| 09/13/2019 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.05 | 193.34% | Marc Goodman74% | $21 → $50 | Upgrade | Market Perform → Outperform | Get Alert |
| 09/12/2019 | AGN | Buy Now | Allergan | — | — | Marc Goodman74% | $172 → $189 | Maintains | Buy | Get Alert |
| 09/12/2019 | ABBV | Buy Now | AbbVie | $199.41 | -60.38% | Marc Goodman74% | $85 → $79 | Upgrade | Neutral → Buy | Get Alert |
| 08/30/2019 | ULTA | Buy Now | Ulta Beauty | $368.00 | -18.48% | Marc Goodman74% | $365 → $300 | Maintains | Buy | Get Alert |
| 05/09/2019 | AGN | Buy Now | Allergan | — | — | Marc Goodman74% | $173 → $172 | Maintains | Buy | Get Alert |
| 04/23/2019 | BHVN | Buy Now | Biohaven | $29.88 | 124.23% | Marc Goodman74% | $50 → $67 | Maintains | Outperform | Get Alert |
| 04/09/2019 | ZGNX | Buy Now | Zogenix | — | — | Marc Goodman74% | $60 → $48 | Maintains | Outperform | Get Alert |
| 04/08/2019 | AXSM | Buy Now | Axsome Therapeutics | $120.69 | -79.28% | Marc Goodman74% | → $25 | Initiates | → Outperform | Get Alert |
| 04/03/2019 | AGN | Buy Now | Allergan | — | — | Marc Goodman74% | $174 → $173 | Maintains | Buy | Get Alert |
| 01/23/2019 | ABBV | Buy Now | AbbVie | $199.41 | -54.37% | Marc Goodman74% | $97 → $91 | Assumes | Neutral → Neutral | Get Alert |
| 12/07/2018 | ULTA | Buy Now | Ulta Beauty | $368.00 | -8.97% | Marc Goodman74% | $315 → $335 | Maintains | Buy | Get Alert |
| 09/07/2018 | ULTA | Buy Now | Ulta Beauty | $368.00 | -14.4% | Marc Goodman74% | $285 → $315 | Maintains | Buy | Get Alert |
| 08/31/2018 | ULTA | Buy Now | Ulta Beauty | $368.00 | -22.55% | Marc Goodman74% | $290 → $285 | Maintains | Buy | Get Alert |
| 05/21/2018 | BMY | Buy Now | Bristol-Myers Squibb | $59.66 | — | Marc Goodman74% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/13/2017 | MNK | Buy Now | Mallinckrodt | — | — | Marc Goodman74% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/10/2017 | DEPO | Buy Now | Depomed | — | — | Marc Goodman74% | $6 → $7 | Maintains | Neutral | Get Alert |
| 11/08/2017 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.28 | 25.11% | Marc Goodman74% | $172 → $168 | Maintains | Buy | Get Alert |
| 10/30/2017 | IPXL | Buy Now | Impax Laboratories | — | — | Marc Goodman74% | $12 → $16 | Maintains | Sell | Get Alert |
| 10/30/2017 | MRK | Buy Now | Merck & Co | $87.46 | -23.39% | Marc Goodman74% | $72 → $67 | Maintains | Buy | Get Alert |
| 10/17/2017 | AGN | Buy Now | Allergan | — | — | Marc Goodman74% | $275 → $255 | Maintains | Buy | Get Alert |
| 10/13/2017 | ABBV | Buy Now | AbbVie | $199.41 | -52.36% | Marc Goodman74% | $92 → $95 | Maintains | Neutral | Get Alert |
| 10/12/2017 | SCMP | Buy Now | Sucampo Pharmaceuticals | — | — | Marc Goodman74% | $19 → $15 | Maintains | Buy | Get Alert |
| 10/06/2017 | BMY | Buy Now | Bristol-Myers Squibb | $59.66 | 20.68% | Marc Goodman74% | $62 → $72 | Maintains | Buy | Get Alert |
| 10/05/2017 | PRGO | Buy Now | Perrigo | $27.74 | 253.28% | Marc Goodman74% | $84 → $98 | Maintains | Buy | Get Alert |
| 09/25/2017 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.28 | 28.09% | Marc Goodman74% | $175 → $172 | Maintains | Buy | Get Alert |
| 09/25/2017 | ABBV | Buy Now | AbbVie | $199.41 | — | Marc Goodman74% | — | Downgrade | Buy → Neutral | Get Alert |
| 07/31/2017 | MRK | Buy Now | Merck & Co | $87.46 | -17.68% | Marc Goodman74% | $70 → $72 | Maintains | Buy | Get Alert |
| 03/20/2017 | NEOS | Buy Now | Neos Therapeutics | — | — | Marc Goodman74% | — | Downgrade | Buy → Neutral | Get Alert |
| 10/03/2016 | DEPO | Buy Now | Depomed | — | — | Marc Goodman74% | $20 → $26 | Maintains | Neutral | Get Alert |
| 08/19/2016 | MRK | Buy Now | Merck & Co | $87.46 | -19.96% | Marc Goodman74% | $62 → $70 | Maintains | Buy | Get Alert |
| 08/03/2016 | MNK | Buy Now | Mallinckrodt | — | — | Marc Goodman74% | $85 → $92 | Maintains | Buy | Get Alert |
| 07/07/2016 | DEPO | Buy Now | Depomed | — | — | Marc Goodman74% | — | Downgrade | Buy → Neutral | Get Alert |
| 02/09/2016 | SCMP | Buy Now | Sucampo Pharmaceuticals | — | — | Marc Goodman74% | → $20 | Initiates | → Buy | Get Alert |
| 02/09/2016 | DEPO | Buy Now | DepoMed | — | — | Marc Goodman74% | → $22 | Initiates | → Buy | Get Alert |
| 11/16/2015 | PRGO | Buy Now | Perrigo | $27.74 | 620.98% | Marc Goodman74% | → $200 | Upgrade | Neutral → Buy | Get Alert |
| 04/27/2015 | PRGO | Buy Now | Perrigo | $27.74 | — | Marc Goodman74% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/17/2015 | IPXL | Buy Now | Impax Laboratories | — | — | Marc Goodman74% | — | Downgrade | Neutral → Sell | Get Alert |
| 02/04/2015 | MNK | Buy Now | Mallinckrodt | — | — | Marc Goodman74% | $107 → $120 | Maintains | Buy | Get Alert |
| 07/22/2014 | AGN | Buy Now | Allergan | — | — | Marc Goodman74% | — | Upgrade | Neutral → Buy | Get Alert |
| 05/09/2014 | MNK | Buy Now | Mallinckrodt | — | — | Marc Goodman74% | $84 → $91 | Maintains | Buy | Get Alert |
| 05/08/2014 | AGN | Buy Now | Allergan | — | — | Marc Goodman74% | $138 → $180 | Downgrade | Buy → Neutral | Get Alert |
| 04/09/2014 | MNK | Buy Now | Mallinckrodt | — | — | Marc Goodman74% | $43 → $84 | Upgrade | Sell → Buy | Get Alert |
| 04/09/2014 | MNK | Buy Now | Mallinckrodt | — | — | Marc Goodman74% | $43 → $84 | Upgrade | Sell → Buy | Get Alert |
| 04/10/2013 | AGN | Buy Now | Allergan | — | — | Marc Goodman74% | $112 → $128 | Maintains | Buy | Get Alert |
| 03/07/2013 | IPXL | Buy Now | Impax Laboratories, Inc. | — | — | Marc Goodman74% | $23 → $17 | Maintains | Neutral | Get Alert |
| 02/25/2013 | PRGO | Buy Now | Perrigo Company | $27.74 | 368.64% | Marc Goodman74% | $115 → $130 | Upgrade | Neutral → Buy | Get Alert |
| 02/25/2013 | PRGO | Buy Now | Perrigo Company | $27.74 | — | Marc Goodman74% | — | Upgrade | Neutral → Buy | Get Alert |
| 07/20/2012 | PRGO | Buy Now | Perrigo | $27.74 | 332.59% | Marc Goodman74% | → $120 | Downgrade | Buy → Neutral | Get Alert |
| 04/10/2012 | IPXL | Buy Now | Impax Laboratories | — | — | Marc Goodman74% | $24 → $26 | Maintains | Neutral | Get Alert |
| 03/29/2012 | AGN | Buy Now | Allergan | — | — | Marc Goodman74% | $100 → $107 | Maintains | Buy | Get Alert |
| 03/05/2012 | PRGO | Buy Now | Perrigo | $27.74 | 332.59% | Marc Goodman74% | $115 → $120 | Maintains | Buy | Get Alert |
| 02/29/2012 | IPXL | Buy Now | Impax Laboratories | — | — | Marc Goodman74% | $21 → $24 | Maintains | Neutral | Get Alert |
